Monod Bio Receives $1.5M Grant to Develop NovoBodies for Next-Generation Tuberculosis Diagnostics

Monod Bio, a biotechnology startup and spinout from the University of Washington’s Institute for Protein Design, announced today that it has received a $1.5M grant from the Gates Foundation to develop a next-generation, rapid diagnostic test for the detection of tuberculosis.